Clinical Trial

Effects of Spirulina Supplementation on Mental Health in Healthy Adults

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 19, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
Spirulina platensis is a form of cyanobacteria, a blue-green algae, and is a superfood most known for being rich in protein, vitamins and minerals, and healthful phytochemicals. Spirulina supports brain health through neuroprotection offered by its antioxidants, anti-inflammatory properties, and hormone regulation. The aim of this study is to supplement healthy adults from a campus community with 3g of spirulina, daily, for 8 weeks to improve mood and mental acuity in comparison to receiving a placebo.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-12.
Status change: Not Yet Recruiting → Recruiting 2025-08-14
Trial Details
NCT Number NCT06936202
Lead Sponsor Arizona State University
Conditions Depression, Mental Acuity
Enrollment 30 participants
Start Date 2025-04-15
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-08-19